Pharmaceuticals News and Research

RSS

At a Tennessee crossroads, two pharmacies, a monkey, and millions of pills

It was about 1 a.m. on April 19, 2016, when a burglary alarm sounded at Dale Hollow Pharmacy in Celina, a tiny town in the rolling, wooded hills near the Kentucky border.

29 Mar 2022

Algal metabolites as novel drugs against viruses

A new review article published in the Journal of Biotechnology has provided information on various nutraceutical metabolites extracted from algae.

29 Mar 2022

Big pharma is betting on bigger political ambitions from Sen. Tim Scott

Sen. Tim Scott, a rising star in the Republican Party with broad popularity in his home state of South Carolina, is getting showered with drug industry money before facing voters this fall.

28 Mar 2022

New implantable biotechnology produces and releases CAR-T cells for attacking tumors

Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed an implantable biotechnology that produces and releases CAR-T cells for attacking cancerous tumors.

24 Mar 2022

Deep-water cone snails produce a potentially painkilling compound, study reports

Scientists already know that the venom of cone snails, which prowl the ocean floor for a fish dinner, contains compounds that can be adapted as pharmaceuticals to treat chronic pain, diabetes and other human maladies.

24 Mar 2022

Pfizer CEO pushes yearly shots for covid. Not so fast, experts say.

When Pfizer CEO Albert Bourla said March 13 that all Americans would need a second booster shot, it struck many covid experts as a self-serving remark without scientific merit. It also set off spasms of doubt over the country's objectives in its fight against the coronavirus.

21 Mar 2022

SEQENS makes multi-million-dollar investment in U.S. R&D laboratory

SEQENS, an integrated leader in the manufacturing of active ingredients and pharmaceutical intermediates, announced a multi-million-dollar investment in its research and development laboratory located in Devens, Mass.

From SEQENS 21 Mar 2022

Texas Biomed and UAB partnership uncovers a new, potent antibody cocktail against all coronaviruses

As SARS-CoV-2 has continued to evolve and outsmart existing treatments, scientists have not let up looking for ever-more effective tools to keep people safe and successfully recover from COVID-19, and to prepare for future outbreaks.

18 Mar 2022

Discovery of key brain pathway offers potential new drug target for treating anxiety

A new target in the brain which underpins the eliciting of anxiety and fear behaviors such as 'freezing' has been identified by neuroscientists.

15 Mar 2022

Zentalis contributes $1 million to SU2C Catalyst program for research into targeted cancer therapeutics

Stand Up To Cancer and Zentalis Pharmaceuticals, Inc. today announced that Zentalis will contribute $1 million to the SU2C Catalyst program to support research that investigates the use of certain small molecule inhibitors for treating a variety of cancer types.

15 Mar 2022

‘An Arm and a Leg’: Need an expensive drug? Here’s what you need to know

Lillian Karabaic teaches personal finance to millennials through a podcast and community called Oh My Dollar! — and she needs an expensive drug to treat a chronic condition.

15 Mar 2022

Study results in three new co-amorphous drug systems with great anti-COVID-19 potential

Researchers demonstrated that the bioavailability of matrine-type alkaloids could be prolonged by employing a co-former, resveratrol.

15 Mar 2022

First genetic rat model of Down syndrome offers better understanding of the condition

In pursuit of better ways to test new therapies and further explore the impacts of the unique genetics associated with Down syndrome, researchers at Johns Hopkins Medicine and Tottori University in Japan have genetically engineered and characterized what is believed to be the first rat model of Down syndrome.

14 Mar 2022

Merck and Waters to Collaborate on Extractables and Leachables Reference Library

Merck, a leading science and technology company, today announced that its Life Science business sector has entered into a collaboration with Waters Corporation to build and expand an Extractables and Leachables (E&L) Reference Library to include ion mobility measurements.

From Merck 11 Mar 2022

Ribociclib plus endocrine therapy offers survival benefit for postmenopausal patients with metastatic breast cancer

A study led by researchers from The University of Texas MD Anderson Cancer Center showed a significant overall survival benefit with ribociclib plus endocrine therapy for postmenopausal patients with hormone receptor-positive (HR+) human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer.

10 Mar 2022

Current progress in SARS-CoV-2 vaccine candidates

Previous
1
...
61
62
63
64
65
66
67
...
1290
Next

Pharmaceuticals News and Research

At a Tennessee crossroads, two pharmacies, a monkey, and millions of pills

Algal metabolites as novel drugs against viruses

Big pharma is betting on bigger political ambitions from Sen. Tim Scott

New implantable biotechnology produces and releases CAR-T cells for attacking tumors

Deep-water cone snails produce a potentially painkilling compound, study reports

Pfizer CEO pushes yearly shots for covid. Not so fast, experts say.

SEQENS makes multi-million-dollar investment in U.S. R&D laboratory

Texas Biomed and UAB partnership uncovers a new, potent antibody cocktail against all coronaviruses

Discovery of key brain pathway offers potential new drug target for treating anxiety

Zentalis contributes $1 million to SU2C Catalyst program for research into targeted cancer therapeutics

‘An Arm and a Leg’: Need an expensive drug? Here’s what you need to know

Study results in three new co-amorphous drug systems with great anti-COVID-19 potential

First genetic rat model of Down syndrome offers better understanding of the condition

Merck and Waters to Collaborate on Extractables and Leachables Reference Library

Ribociclib plus endocrine therapy offers survival benefit for postmenopausal patients with metastatic breast cancer

Current progress in SARS-CoV-2 vaccine candidates

Patients divided over Alzheimer’s drug: Is it a ‘risk I’m willing to take’ or just a ‘magic pill’?

$35 insulin cap is welcome, popular, and bipartisan. But Congress may not pass it anyway.

California governor’s big promises on drug prices are slow to materialize

COVID-19 and the life sciences; what have we learned and where are we going?

Event guide: World ADC London eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring